Skip to content
Politically.com Search all
Menu

South Dakota 2026

HB 1099

reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Open original source Back to bills
Source: Open States / PluralLatest available (refresh delayed). Last refreshed: 2026-11-08 08:11:14 UTC.

Official record

Measure details

Jurisdiction
South Dakota
Session
2026
Chamber
lower
Classification
bill
Subjects
Controlled Substances, Public Health and Safety
Introduced / first action
2026-01-21 00:00:00

Sponsors

Source-supplied history

Actions

  1. Signed by the Governor on 2026-03-10 H.J. 547

    executive-signature

  2. Delivered to the Governor on 2026-03-05 H.J. 520

    executive-receipt

  3. Signed by the President S.J. 470

    passage

  4. Signed by the Speaker H.J. 492

    passage

  5. Senate Do Pass , Passed, YEAS 21, NAYS 12 S.J. 429

    passage

  6. Remove from Consent Calendar S.J. 412

  7. Certified uncontested, placed on consent , Passed, S.J. 21

  8. Health and Human Services Do Pass , Passed, YEAS 6, NAYS 0 S.J. 21

    committee-passage

  9. Scheduled for hearing S.J. 1

  10. First read in Senate and referred to Senate Health and Human Services S.J. 232

    introduction, reading-1, referral-committee

  11. House of Representatives Do Pass , Passed, YEAS 58, NAYS 7 H.J. 265

    passage

  12. Health and Human Services Do Pass , Passed, YEAS 13, NAYS 0 H.J. 13

    committee-passage

  13. Scheduled for hearing H.J. 1

  14. First read in House and referred to House Health and Human Services H.J. 104

    introduction, reading-1, referral-committee

When supplied by the API

Related measures

No resolvable related measure is supplied.